Stock Scorecard
Stock Summary for Guardant Health Inc (GH) - $58.88 as of 8/18/2025 10:32:02 AM EST
Total Score
5 out of 30
Safety Score
42 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for GH
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for GH
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for GH
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for GH
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for GH (42 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for GH
Financial Details for GH
Company Overview |
|
|---|---|
| Ticker | GH |
| Company Name | Guardant Health Inc |
| Country | USA |
| Description | Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-MEDICAL LABORATORIES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/30/2025 |
Stock Price History |
|
| Last Day Price | 58.88 |
| Price 4 Years Ago | 100.02 |
| Last Day Price Updated | 8/18/2025 10:32:02 AM EST |
| Last Day Volume | 3,196,547 |
| Average Daily Volume | 2,776,527 |
| 52-Week High | 60.68 |
| 52-Week Low | 20.14 |
| Last Price to 52 Week Low | 192.35% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 32.76 |
| Sector PE | 59.06 |
| 5-Year Average PE | -20.62 |
| Free Cash Flow Ratio | 11.66 |
| Industry Free Cash Flow Ratio | 23.79 |
| Sector Free Cash Flow Ratio | 30.26 |
| Current Ratio Most Recent Quarter | 3.71 |
| Total Cash Per Share | 5.05 |
| Book Value Per Share Most Recent Quarter | -2.45 |
| Price to Book Ratio | 55.67 |
| Industry Price to Book Ratio | 1.99 |
| Sector Price to Book Ratio | 26.93 |
| Price to Sales Ratio Twelve Trailing Months | 9.08 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.21 |
| Analyst Buy Ratings | 16 |
| Analyst Strong Buy Ratings | 6 |
Share Statistics |
|
| Total Shares Outstanding | 124,706,000 |
| Market Capitalization | 7,342,689,280 |
| Institutional Ownership | 100.93% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 8.98% |
| Reported EPS 12 Trailing Months | -3.35 |
| Reported EPS Past Year | -0.93 |
| Reported EPS Prior Year | -3.28 |
| Net Income Twelve Trailing Months | -413,818,000 |
| Net Income Past Year | -436,373,000 |
| Net Income Prior Year | -479,449,000 |
| Quarterly Revenue Growth YOY | 30.90% |
| 5-Year Revenue Growth | 28.08% |
| Operating Margin Twelve Trailing Months | -45.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 629,143,000 |
| Total Cash Past Year | 525,540,000 |
| Total Cash Prior Year | 1,133,537,000 |
| Net Cash Position Most Recent Quarter | -486,383,000 |
| Net Cash Position Past Year | -617,007,000 |
| Long Term Debt Past Year | 1,142,547,000 |
| Long Term Debt Prior Year | 1,139,966,000 |
| Total Debt Most Recent Quarter | 1,115,526,000 |
| Equity to Debt Ratio Past Year | -0.14 |
| Equity to Debt Ratio Most Recent Quarter | -0.38 |
| Total Stockholder Equity Past Year | -139,647,000 |
| Total Stockholder Equity Prior Year | 158,684,000 |
| Total Stockholder Equity Most Recent Quarter | -305,475,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -271,728,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -2.18 |
| Free Cash Flow Past Year | -274,943,000 |
| Free Cash Flow Prior Year | -345,461,000 |
Options |
|
| Put/Call Ratio | 0.91 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 2.02 |
| MACD Signal | 0.53 |
| 20-Day Bollinger Lower Band | 35.93 |
| 20-Day Bollinger Middle Band | 46.52 |
| 20-Day Bollinger Upper Band | 57.11 |
| Beta | 1.44 |
| RSI | 72.51 |
| 50-Day SMA | 38.24 |
| 150-Day SMA | 32.74 |
| 200-Day SMA | 41.28 |
System |
|
| Modified | 8/16/2025 12:39:15 AM EST |